Edition:
United Kingdom

ESSA Pharma Inc (EPIX.OQ)

EPIX.OQ on NASDAQ Stock Exchange Capital Market

0.22USD
4:57pm GMT
Change (% chg)

$-0.01 (-4.26%)
Prev Close
$0.23
Open
$0.22
Day's High
$0.22
Day's Low
$0.22
Volume
1,835
Avg. Vol
26,257
52-wk High
$3.59
52-wk Low
$0.16

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- September 22 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.33 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Sep-18 1 0.00 0.00 0.00 --
Earnings (per share)
Year Ending Sep-18 2 -0.38 -0.09 -0.68 --

Historical Surprises

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-15 0.00 0.00 0.00 0.00
Quarter Ending Sep-15 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-17 -0.22 -0.11 0.11 -48.45
Quarter Ending Jun-17 -0.20 -0.16 0.04 -20.95
Quarter Ending Mar-17 -0.14 -0.19 0.05 -32.13
Quarter Ending Dec-15 -0.17 -0.19 0.02 -11.76
Quarter Ending Sep-15 -0.07 0.08 0.15 -214.29

Consensus Estimates Trend

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Sep-18 0.00 0.00 0.00 0.00 --
Earnings (per share)
Year Ending Sep-18 -0.38 -0.68 -0.68 -0.68 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Sep-18 0 0 0 0
Earnings
Year Ending Sep-18 0 0 0 0